Drug Profile
DW 286
Alternative Names: DW 286a; DW286Latest Information Update: 01 Sep 2010
Price :
$50
*
At a glance
- Originator Dong Wha
- Developer Dong Wha Pharmaceutical
- Class Antibacterials; Naphthyridines
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 01 Sep 2010 Discontinued - Phase-I for Bacterial infections in South Korea (PO)
- 16 Feb 2006 Phase-I clinical trials in Bacterial infections in South Korea (PO)
- 06 Jul 2005 This compound is still in active development